Gitlab Inc.: Form 10-Q for the period ended Oct 31, 2025
Filed with the SEC on Dec 3, 2025 and accepted by EDGAR at Dec 2, 2025, 17:43 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-10-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-08-01 to 2025-10-31 | $244.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-02-01 to 2025-10-31 | $694.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-08-01 to 2025-10-31 | $32.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2025-02-01 to 2025-10-31 | $85.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2025-08-01 to 2025-10-31 | $212.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-02-01 to 2025-10-31 | $609.1m | us-gaap:GrossProfit |
| Research and development | 3 months2025-08-01 to 2025-10-31 | $68.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-02-01 to 2025-10-31 | $205.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-08-01 to 2025-10-31 | −$12.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-02-01 to 2025-10-31 | −$65.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-08-01 to 2025-10-31 | $1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-02-01 to 2025-10-31 | $6.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-08-01 to 2025-10-31 | −$8.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-02-01 to 2025-10-31 | −$53.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-08-01 to 2025-10-31 | −$0.05 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-02-01 to 2025-10-31 | −$0.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-08-01 to 2025-10-31 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-02-01 to 2025-10-31 | −$0.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-08-01 to 2025-10-31 | 167,407,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-02-01 to 2025-10-31 | 165,965,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-02-01 to 2025-10-31 | $187.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-02-01 to 2025-10-31 | $6.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-10-31 | $224.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-10-31 | $1.51bn | us-gaap:AssetsCurrent |
| Total assets | At period end2025-10-31 | $1.57bn | us-gaap:Assets |
| Current liabilities | At period end2025-10-31 | $565.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-10-31 | $602.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-10-31 | $922.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-25-054840. Last ingested by Listed: Oct 30, 2026, 16:31 ET. Listed shows no prices and gives no investment advice.